(347685, 'HP:0006528', 'Chronic lung disease', 'MP:0006273', 'abnormal urine organic cation level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347686, 'HP:0006528', 'Chronic lung disease', 'MP:0005253', 'abnormal eye physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347687, 'HP:0006528', 'Chronic lung disease', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347688, 'HP:0006528', 'Chronic lung disease', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347689, 'HP:0006528', 'Chronic lung disease', 'MP:0006047', 'aortic valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347690, 'HP:0006528', 'Chronic lung disease', 'MP:0013555', 'abnormal apocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347691, 'HP:0006528', 'Chronic lung disease', 'MP:0001533', 'abnormal skeleton physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347692, 'HP:0006528', 'Chronic lung disease', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347693, 'HP:0006528', 'Chronic lung disease', 'MP:0004022', 'abnormal cone electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347694, 'HP:0006528', 'Chronic lung disease', 'MP:0013971', 'blood in lymph vessels', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347695, 'HP:0006528', 'Chronic lung disease', 'MP:0010394', 'decreased QRS amplitude', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347696, 'HP:0006528', 'Chronic lung disease', 'MP:0012556', 'increased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347697, 'HP:0006528', 'Chronic lung disease', 'MP:0013644', 'increased vertebra maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347698, 'HP:0006528', 'Chronic lung disease', 'MP:0008564', 'increased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347699, 'HP:0006528', 'Chronic lung disease', 'MP:0008145', 'hemeralopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347700, 'HP:0006528', 'Chronic lung disease', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347701, 'HP:0006528', 'Chronic lung disease', 'MP:0010571', 'shortened ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347702, 'HP:0006528', 'Chronic lung disease', 'MP:0031471', 'abnormal micropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347703, 'HP:0006528', 'Chronic lung disease', 'MP:0012032', 'abnormal ERG latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347704, 'HP:0006528', 'Chronic lung disease', 'MP:0020155', 'enhanced humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347705, 'HP:0006528', 'Chronic lung disease', 'MP:0008877', 'abnormal DNA methylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347706, 'HP:0006528', 'Chronic lung disease', 'MP:0013641', 'increased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347707, 'HP:0006528', 'Chronic lung disease', 'MP:0031469', 'abnormal pinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347708, 'HP:0006528', 'Chronic lung disease', 'MP:0011444', 'abnormal renal water homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347709, 'HP:0006528', 'Chronic lung disease', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347710, 'HP:0006528', 'Chronic lung disease', 'MP:0003777', 'lip inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347711, 'HP:0006528', 'Chronic lung disease', 'MP:0003259', 'nausea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347712, 'HP:0006528', 'Chronic lung disease', 'MP:0010631', 'increased Q wave amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347713, 'HP:0006528', 'Chronic lung disease', 'MP:0004144', 'hypotonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347714, 'HP:0006528', 'Chronic lung disease', 'MP:0013468', 'chromodacryorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347715, 'HP:0006528', 'Chronic lung disease', 'MP:0009562', 'abnormal odor adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347716, 'HP:0006528', 'Chronic lung disease', 'MP:0004145', 'abnormal muscle electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347717, 'HP:0006528', 'Chronic lung disease', 'MP:0005574', 'decreased pulmonary respiratory rate', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347718, 'HP:0006528', 'Chronic lung disease', 'MP:0000327', 'hemosiderinuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347719, 'HP:0006528', 'Chronic lung disease', 'MP:0002334', 'abnormal airway responsiveness', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347720, 'HP:0006528', 'Chronic lung disease', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347721, 'HP:0006528', 'Chronic lung disease', 'MP:0001934', 'increased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347722, 'HP:0006528', 'Chronic lung disease', 'MP:0001790', 'abnormal immune system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347723, 'HP:0006528', 'Chronic lung disease', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347724, 'HP:0006528', 'Chronic lung disease', 'MP:0002694', 'abnormal pancreas secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347725, 'HP:0006528', 'Chronic lung disease', 'MP:0000350', 'abnormal cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347726, 'HP:0006528', 'Chronic lung disease', 'MP:0002634', 'abnormal sensorimotor gating', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347727, 'HP:0006528', 'Chronic lung disease', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347728, 'HP:0006528', 'Chronic lung disease', 'MP:0008006', 'increased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347729, 'HP:0006528', 'Chronic lung disease', 'MP:0002998', 'abnormal bone remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347730, 'HP:0006528', 'Chronic lung disease', 'MP:0010994', 'aerophagia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347731, 'HP:0006528', 'Chronic lung disease', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347732, 'HP:0006528', 'Chronic lung disease', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347733, 'HP:0006528', 'Chronic lung disease', 'MP:0012697', 'abnormal maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347734, 'HP:0006528', 'Chronic lung disease', 'MP:0008007', 'abnormal cellular replicative senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347735, 'HP:0006528', 'Chronic lung disease', 'MP:0031054', 'bronchiolitis', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347736, 'HP:0006528', 'Chronic lung disease', 'MP:0010073', 'decreased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347737, 'HP:0006528', 'Chronic lung disease', 'MP:0010519', 'atrioventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347738, 'HP:0006528', 'Chronic lung disease', 'MP:0008709', 'decreased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347739, 'HP:0006528', 'Chronic lung disease', 'MP:0013561', 'abnormal endocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347740, 'HP:0006528', 'Chronic lung disease', 'MP:0010072', 'increased pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347741, 'HP:0006528', 'Chronic lung disease', 'MP:0031013', 'abnormal egg activation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347742, 'HP:0006528', 'Chronic lung disease', 'MP:0003660', 'chylothorax', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347743, 'HP:0006528', 'Chronic lung disease', 'MP:0008748', 'abnormal central T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347744, 'HP:0006528', 'Chronic lung disease', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347745, 'HP:0006528', 'Chronic lung disease', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347746, 'HP:0006528', 'Chronic lung disease', 'MP:0001963', 'abnormal hearing physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347747, 'HP:0006528', 'Chronic lung disease', 'MP:0003698', 'abnormal male reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347748, 'HP:0006528', 'Chronic lung disease', 'MP:0001861', 'lung inflammation', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347749, 'HP:0006528', 'Chronic lung disease', 'MP:0002626', 'increased heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347750, 'HP:0006528', 'Chronic lung disease', 'MP:0010071', 'abnormal pruritus', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347751, 'HP:0006528', 'Chronic lung disease', 'MP:0001666', 'abnormal intestinal absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347752, 'HP:0006528', 'Chronic lung disease', 'MP:0004736', 'abnormal distortion product otoacoustic emission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347753, 'HP:0006528', 'Chronic lung disease', 'MP:0031105', 'rhonchi', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347754, 'HP:0006528', 'Chronic lung disease', 'MP:0030214', 'muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347755, 'HP:0006528', 'Chronic lung disease', 'MP:0004945', 'abnormal bone resorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347756, 'HP:0006528', 'Chronic lung disease', 'MP:0005575', 'increased pulmonary ventilation', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347757, 'HP:0006528', 'Chronic lung disease', 'MP:0011418', 'leukocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347758, 'HP:0006528', 'Chronic lung disease', 'MP:0030215', 'facial muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347759, 'HP:0006528', 'Chronic lung disease', 'MP:0001953', 'respiratory failure', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347760, 'HP:0006528', 'Chronic lung disease', 'MP:0003741', 'tinnitus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347761, 'HP:0006528', 'Chronic lung disease', 'MP:0001633', 'poor circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347762, 'HP:0006528', 'Chronic lung disease', 'MP:0000064', 'failure of bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347763, 'HP:0006528', 'Chronic lung disease', 'MP:0001985', 'abnormal gustatory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347764, 'HP:0006528', 'Chronic lung disease', 'MP:0003298', 'choking', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347765, 'HP:0006528', 'Chronic lung disease', 'MP:0006190', 'retina ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347766, 'HP:0006528', 'Chronic lung disease', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347767, 'HP:0006528', 'Chronic lung disease', 'MP:0000351', 'increased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347768, 'HP:0006528', 'Chronic lung disease', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347769, 'HP:0006528', 'Chronic lung disease', 'MP:0004738', 'abnormal auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347770, 'HP:0006528', 'Chronic lung disease', 'MP:0002419', 'abnormal innate immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347771, 'HP:0006528', 'Chronic lung disease', 'MP:0003034', 'increased pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347772, 'HP:0006528', 'Chronic lung disease', 'MP:0004743', 'abnormal vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347773, 'HP:0006528', 'Chronic lung disease', 'MP:0010559', 'heart block', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347774, 'HP:0006528', 'Chronic lung disease', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347775, 'HP:0006528', 'Chronic lung disease', 'MP:0008995', 'early reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347776, 'HP:0006528', 'Chronic lung disease', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347777, 'HP:0006528', 'Chronic lung disease', 'MP:0010510', 'absent P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347778, 'HP:0006528', 'Chronic lung disease', 'MP:0021010', 'impaired synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347779, 'HP:0006528', 'Chronic lung disease', 'MP:0012382', 'abnormal blood cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347780, 'HP:0006528', 'Chronic lung disease', 'MP:0003901', 'abnormal PR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347781, 'HP:0006528', 'Chronic lung disease', 'MP:0005410', 'abnormal fertilization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347782, 'HP:0006528', 'Chronic lung disease', 'MP:0009698', 'heart hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347783, 'HP:0006528', 'Chronic lung disease', 'MP:0003866', 'abnormal defecation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347784, 'HP:0006528', 'Chronic lung disease', 'MP:0002296', 'aspiration', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347785, 'HP:0006528', 'Chronic lung disease', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347786, 'HP:0006528', 'Chronic lung disease', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347787, 'HP:0006528', 'Chronic lung disease', 'MP:0011431', 'increased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347788, 'HP:0006528', 'Chronic lung disease', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347789, 'HP:0006528', 'Chronic lung disease', 'MP:0004072', 'abnormal frontal plane axis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347790, 'HP:0006528', 'Chronic lung disease', 'MP:0030118', 'rhinosinusitis', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347791, 'HP:0006528', 'Chronic lung disease', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347792, 'HP:0006528', 'Chronic lung disease', 'MP:0008562', 'increased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347793, 'HP:0006528', 'Chronic lung disease', 'MP:0005621', 'abnormal cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347794, 'HP:0006528', 'Chronic lung disease', 'MP:0009247', 'meteorism', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347795, 'HP:0006528', 'Chronic lung disease', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347796, 'HP:0006528', 'Chronic lung disease', 'MP:0000249', 'abnormal blood vessel physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347797, 'HP:0006528', 'Chronic lung disease', 'MP:0011467', 'decreased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347798, 'HP:0006528', 'Chronic lung disease', 'MP:0003762', 'abnormal immune organ physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347799, 'HP:0006528', 'Chronic lung disease', 'MP:0004780', 'abnormal surfactant secretion', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347800, 'HP:0006528', 'Chronic lung disease', 'MP:0020974', 'abnormal FO-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347801, 'HP:0006528', 'Chronic lung disease', 'MP:0004748', 'increased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347802, 'HP:0006528', 'Chronic lung disease', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347803, 'HP:0006528', 'Chronic lung disease', 'MP:0001927', 'abnormal estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347804, 'HP:0006528', 'Chronic lung disease', 'MP:0001954', 'respiratory distress', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347805, 'HP:0006528', 'Chronic lung disease', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347806, 'HP:0006528', 'Chronic lung disease', 'MP:0031127', 'dry gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347807, 'HP:0006528', 'Chronic lung disease', 'MP:0004513', 'avnosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347808, 'HP:0006528', 'Chronic lung disease', 'MP:0031128', 'cardiovascular shunt', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347809, 'HP:0006528', 'Chronic lung disease', 'MP:0001957', 'apnea', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347810, 'HP:0006528', 'Chronic lung disease', 'MP:0003077', 'abnormal cell cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347811, 'HP:0006528', 'Chronic lung disease', 'MP:0005435', 'hemoperitoneum', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347812, 'HP:0006528', 'Chronic lung disease', 'MP:0020381', 'muscle gating pore current', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347813, 'HP:0006528', 'Chronic lung disease', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347814, 'HP:0006528', 'Chronic lung disease', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347815, 'HP:0006528', 'Chronic lung disease', 'MP:0008817', 'hematoma', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347816, 'HP:0006528', 'Chronic lung disease', 'MP:0000743', 'muscle spasm', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347817, 'HP:0006528', 'Chronic lung disease', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347818, 'HP:0006528', 'Chronic lung disease', 'MP:0013556', 'abnormal holocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347819, 'HP:0006528', 'Chronic lung disease', 'MP:0021016', 'decreased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347820, 'HP:0006528', 'Chronic lung disease', 'MP:0001727', 'abnormal embryo implantation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347821, 'HP:0006528', 'Chronic lung disease', 'MP:0013642', 'decreased vertebra stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347822, 'HP:0006528', 'Chronic lung disease', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 6.810566817447846, 1.6845581539194787, 'UPHENO:0004536', 'abnormal respiratory system'),
(347823, 'HP:0006528', 'Chronic lung disease', 'MP:0003997', 'tonic-clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347824, 'HP:0006528', 'Chronic lung disease', 'MP:0013145', 'eye discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347825, 'HP:0006528', 'Chronic lung disease', 'MP:0010554', 'shortened HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347826, 'HP:0006528', 'Chronic lung disease', 'MP:0011931', 'abnormal pulmonary valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347827, 'HP:0006528', 'Chronic lung disease', 'MP:0004085', 'abnormal heartbeat', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347828, 'HP:0006528', 'Chronic lung disease', 'MP:0014046', 'abnormal mitophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347829, 'HP:0006528', 'Chronic lung disease', 'MP:0002327', 'abnormal respiratory function', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347830, 'HP:0006528', 'Chronic lung disease', 'MP:0011825', 'decreased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347831, 'HP:0006528', 'Chronic lung disease', 'MP:0006002', 'abnormal small intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347832, 'HP:0006528', 'Chronic lung disease', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347833, 'HP:0006528', 'Chronic lung disease', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347834, 'HP:0006528', 'Chronic lung disease', 'MP:0003482', 'increased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347835, 'HP:0006528', 'Chronic lung disease', 'MP:0010393', 'shortened QRS complex duration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347836, 'HP:0006528', 'Chronic lung disease', 'MP:0001648', 'abnormal apoptosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347837, 'HP:0006528', 'Chronic lung disease', 'MP:0013639', 'decreased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347838, 'HP:0006528', 'Chronic lung disease', 'MP:0001627', 'abnormal cardiac output', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347839, 'HP:0006528', 'Chronic lung disease', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347840, 'HP:0006528', 'Chronic lung disease', 'MP:0031307', 'bronchomalacia', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347841, 'HP:0006528', 'Chronic lung disease', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347842, 'HP:0006528', 'Chronic lung disease', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347843, 'HP:0006528', 'Chronic lung disease', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347844, 'HP:0006528', 'Chronic lung disease', 'MP:0006266', 'decreased pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347845, 'HP:0006528', 'Chronic lung disease', 'MP:0002338', 'abnormal pulmonary ventilation', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347846, 'HP:0006528', 'Chronic lung disease', 'MP:0010513', 'abnormal ventricular activation time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347847, 'HP:0006528', 'Chronic lung disease', 'MP:0004014', 'abnormal uterine environment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347848, 'HP:0006528', 'Chronic lung disease', 'MP:0004760', 'increased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347849, 'HP:0006528', 'Chronic lung disease', 'MP:0011046', 'abnormal lung tissue damping', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347850, 'HP:0006528', 'Chronic lung disease', 'MP:0003474', 'abnormal summary potential intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347851, 'HP:0006528', 'Chronic lung disease', 'MP:0002164', 'abnormal gland physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347852, 'HP:0006528', 'Chronic lung disease', 'MP:0030988', 'dysosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347853, 'HP:0006528', 'Chronic lung disease', 'MP:0010935', 'increased airway resistance', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347854, 'HP:0006528', 'Chronic lung disease', 'MP:0012201', 'decreased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347855, 'HP:0006528', 'Chronic lung disease', 'MP:0004156', 'abnormal QT variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347856, 'HP:0006528', 'Chronic lung disease', 'MP:0000304', 'abnormal cardiac stroke volume', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347857, 'HP:0006528', 'Chronic lung disease', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347858, 'HP:0006528', 'Chronic lung disease', 'MP:0001634', 'internal hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347859, 'HP:0006528', 'Chronic lung disease', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347860, 'HP:0006528', 'Chronic lung disease', 'MP:0013305', 'isosthenuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347861, 'HP:0006528', 'Chronic lung disease', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347862, 'HP:0006528', 'Chronic lung disease', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347863, 'HP:0006528', 'Chronic lung disease', 'MP:0010512', 'absent PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347864, 'HP:0006528', 'Chronic lung disease', 'MP:0003039', 'increased time of peak ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347865, 'HP:0006528', 'Chronic lung disease', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347866, 'HP:0006528', 'Chronic lung disease', 'MP:0008699', 'increased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347867, 'HP:0006528', 'Chronic lung disease', 'MP:0031086', 'wheezing', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347868, 'HP:0006528', 'Chronic lung disease', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347869, 'HP:0006528', 'Chronic lung disease', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347870, 'HP:0006528', 'Chronic lung disease', 'MP:0011929', 'abnormal aortic valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347871, 'HP:0006528', 'Chronic lung disease', 'MP:0031170', 'abnormal vasculature physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347872, 'HP:0006528', 'Chronic lung disease', 'MP:0031423', 'abnormal luteolysis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347873, 'HP:0006528', 'Chronic lung disease', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347874, 'HP:0006528', 'Chronic lung disease', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347875, 'HP:0006528', 'Chronic lung disease', 'MP:0010895', 'increased lung compliance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347876, 'HP:0006528', 'Chronic lung disease', 'MP:0003261', 'hematemesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347877, 'HP:0006528', 'Chronic lung disease', 'MP:0008402', 'increased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347878, 'HP:0006528', 'Chronic lung disease', 'MP:0005333', 'decreased heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347879, 'HP:0006528', 'Chronic lung disease', 'MP:0010957', 'abnormal aerobic respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347880, 'HP:0006528', 'Chronic lung disease', 'MP:0006153', 'hypermetropia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347881, 'HP:0006528', 'Chronic lung disease', 'MP:0011220', 'increased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347882, 'HP:0006528', 'Chronic lung disease', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347883, 'HP:0006528', 'Chronic lung disease', 'MP:0008565', 'decreased interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347884, 'HP:0006528', 'Chronic lung disease', 'MP:0004759', 'decreased mitotic index', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347885, 'HP:0006528', 'Chronic lung disease', 'MP:0000503', 'excessive digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347886, 'HP:0006528', 'Chronic lung disease', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347887, 'HP:0006528', 'Chronic lung disease', 'MP:0011702', 'abnormal fibroblast proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347888, 'HP:0006528', 'Chronic lung disease', 'MP:0011045', 'decreased lung elastance', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347889, 'HP:0006528', 'Chronic lung disease', 'MP:0002500', 'granulomatous inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347890, 'HP:0006528', 'Chronic lung disease', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347891, 'HP:0006528', 'Chronic lung disease', 'MP:0001844', 'autoimmune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347892, 'HP:0006528', 'Chronic lung disease', 'MP:0011518', 'abnormal cell chemotaxis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347893, 'HP:0006528', 'Chronic lung disease', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347894, 'HP:0006528', 'Chronic lung disease', 'MP:0009358', 'environmentally induced seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347895, 'HP:0006528', 'Chronic lung disease', 'MP:0008712', 'decreased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347896, 'HP:0006528', 'Chronic lung disease', 'MP:0005076', 'abnormal cell differentiation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347897, 'HP:0006528', 'Chronic lung disease', 'MP:0030619', 'homogentisic aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347898, 'HP:0006528', 'Chronic lung disease', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347899, 'HP:0006528', 'Chronic lung disease', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347900, 'HP:0006528', 'Chronic lung disease', 'MP:0031308', 'tracheobronchomalacia', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347901, 'HP:0006528', 'Chronic lung disease', 'MP:0001952', 'increased airway responsiveness', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347902, 'HP:0006528', 'Chronic lung disease', 'MP:0020220', 'decreased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347903, 'HP:0006528', 'Chronic lung disease', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347904, 'HP:0006528', 'Chronic lung disease', 'MP:0011994', 'increased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347905, 'HP:0006528', 'Chronic lung disease', 'MP:0030216', 'tongue muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347906, 'HP:0006528', 'Chronic lung disease', 'MP:0004216', 'salt-resistant hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347907, 'HP:0006528', 'Chronic lung disease', 'MP:0004597', 'increased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347908, 'HP:0006528', 'Chronic lung disease', 'MP:0010514', 'fragmented QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347909, 'HP:0006528', 'Chronic lung disease', 'MP:0008814', 'decreased nerve conduction velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347910, 'HP:0006528', 'Chronic lung disease', 'MP:0003480', 'increased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347911, 'HP:0006528', 'Chronic lung disease', 'MP:0031481', 'decreased urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347912, 'HP:0006528', 'Chronic lung disease', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347913, 'HP:0006528', 'Chronic lung disease', 'MP:0008744', 'abnormal B cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347914, 'HP:0006528', 'Chronic lung disease', 'MP:0003476', 'decreased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347915, 'HP:0006528', 'Chronic lung disease', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347916, 'HP:0006528', 'Chronic lung disease', 'MP:0013285', 'abnormal renal filtration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347917, 'HP:0006528', 'Chronic lung disease', 'MP:0001761', 'abnormal urination pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347918, 'HP:0006528', 'Chronic lung disease', 'MP:0011936', 'abnormal PP interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347919, 'HP:0006528', 'Chronic lung disease', 'MP:0006335', 'abnormal hearing electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347920, 'HP:0006528', 'Chronic lung disease', 'MP:0009062', 'impaired lectin complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347921, 'HP:0006528', 'Chronic lung disease', 'MP:0008679', 'decreased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347922, 'HP:0006528', 'Chronic lung disease', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347923, 'HP:0006528', 'Chronic lung disease', 'MP:0003100', 'myopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347924, 'HP:0006528', 'Chronic lung disease', 'MP:0008942', 'abnormal induced cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347925, 'HP:0006528', 'Chronic lung disease', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347926, 'HP:0006528', 'Chronic lung disease', 'MP:0008555', 'abnormal interferon secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347927, 'HP:0006528', 'Chronic lung disease', 'MP:0010107', 'abnormal renal reabsorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347928, 'HP:0006528', 'Chronic lung disease', 'MP:0008675', 'increased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347929, 'HP:0006528', 'Chronic lung disease', 'MP:0003897', 'abnormal ST segment', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347930, 'HP:0006528', 'Chronic lung disease', 'MP:0001800', 'abnormal humoral immune response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347931, 'HP:0006528', 'Chronic lung disease', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347932, 'HP:0006528', 'Chronic lung disease', 'MP:0008664', 'decreased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347933, 'HP:0006528', 'Chronic lung disease', 'MP:0001542', 'abnormal bone strength', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347934, 'HP:0006528', 'Chronic lung disease', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347935, 'HP:0006528', 'Chronic lung disease', 'MP:0000352', 'decreased cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347936, 'HP:0006528', 'Chronic lung disease', 'MP:0008681', 'increased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347937, 'HP:0006528', 'Chronic lung disease', 'MP:0002876', 'abnormal thyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347938, 'HP:0006528', 'Chronic lung disease', 'MP:0005620', 'abnormal muscle contractility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347939, 'HP:0006528', 'Chronic lung disease', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347940, 'HP:0006528', 'Chronic lung disease', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347941, 'HP:0006528', 'Chronic lung disease', 'MP:0003089', 'decreased skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347942, 'HP:0006528', 'Chronic lung disease', 'MP:0008563', 'decreased interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347943, 'HP:0006528', 'Chronic lung disease', 'MP:0014274', 'decreased respiration', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347944, 'HP:0006528', 'Chronic lung disease', 'MP:0001950', 'abnormal respiratory sounds', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347945, 'HP:0006528', 'Chronic lung disease', 'MP:0004213', 'abnormal umami taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347946, 'HP:0006528', 'Chronic lung disease', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347947, 'HP:0006528', 'Chronic lung disease', 'MP:0004773', 'abnormal bile composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347948, 'HP:0006528', 'Chronic lung disease', 'MP:0006048', 'pulmonary valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347949, 'HP:0006528', 'Chronic lung disease', 'MP:0003880', 'abnormal central pattern generator function', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347950, 'HP:0006528', 'Chronic lung disease', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347951, 'HP:0006528', 'Chronic lung disease', 'MP:0013135', 'poor circulation in tail', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347952, 'HP:0006528', 'Chronic lung disease', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347953, 'HP:0006528', 'Chronic lung disease', 'MP:0003469', 'decreased single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347954, 'HP:0006528', 'Chronic lung disease', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347955, 'HP:0006528', 'Chronic lung disease', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347956, 'HP:0006528', 'Chronic lung disease', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347957, 'HP:0006528', 'Chronic lung disease', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347958, 'HP:0006528', 'Chronic lung disease', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347959, 'HP:0006528', 'Chronic lung disease', 'MP:0009344', 'abnormal ovulation cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347960, 'HP:0006528', 'Chronic lung disease', 'MP:0011012', 'bronchiectasis', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347961, 'HP:0006528', 'Chronic lung disease', 'MP:0031221', 'abnormal CXCL10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347962, 'HP:0006528', 'Chronic lung disease', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347963, 'HP:0006528', 'Chronic lung disease', 'MP:0008747', 'abnormal T cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347964, 'HP:0006528', 'Chronic lung disease', 'MP:0031169', 'abnormal joint physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347965, 'HP:0006528', 'Chronic lung disease', 'MP:0001867', 'rhinitis', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347966, 'HP:0006528', 'Chronic lung disease', 'MP:0002064', 'seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347967, 'HP:0006528', 'Chronic lung disease', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347968, 'HP:0006528', 'Chronic lung disease', 'MP:0005005', 'abnormal self tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347969, 'HP:0006528', 'Chronic lung disease', 'MP:0004878', 'increased systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347970, 'HP:0006528', 'Chronic lung disease', 'MP:0012011', 'febrile seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347971, 'HP:0006528', 'Chronic lung disease', 'MP:0030951', 'abnormal endocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347972, 'HP:0006528', 'Chronic lung disease', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347973, 'HP:0006528', 'Chronic lung disease', 'MP:0011013', 'bronchiolectasis', 0.4375, 8.526773851447254, 1.9314407989913058, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347974, 'HP:0006528', 'Chronic lung disease', 'MP:0004217', 'salt-sensitive hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347975, 'HP:0006528', 'Chronic lung disease', 'MP:0008672', 'increased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347976, 'HP:0006528', 'Chronic lung disease', 'MP:0010552', 'abnormal HV interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347977, 'HP:0006528', 'Chronic lung disease', 'MP:0003193', 'decreased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347978, 'HP:0006528', 'Chronic lung disease', 'MP:0010637', 'sinus bradycardia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347979, 'HP:0006528', 'Chronic lung disease', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347980, 'HP:0006528', 'Chronic lung disease', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347981, 'HP:0006528', 'Chronic lung disease', 'MP:0012006', 'abnormal hippocampus physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347982, 'HP:0006528', 'Chronic lung disease', 'MP:0010516', 'absent Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347983, 'HP:0006528', 'Chronic lung disease', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347984, 'HP:0006528', 'Chronic lung disease', 'MP:0030153', 'dental pulp inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347985, 'HP:0006528', 'Chronic lung disease', 'MP:0003464', 'abnormal single cell response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347986, 'HP:0006528', 'Chronic lung disease', 'MP:0003635', 'abnormal synaptic transmission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347987, 'HP:0006528', 'Chronic lung disease', 'MP:0003878', 'abnormal ear physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347988, 'HP:0006528', 'Chronic lung disease', 'MP:0001835', 'abnormal antigen presentation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347989, 'HP:0006528', 'Chronic lung disease', 'MP:0011930', 'abnormal tricuspid valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347990, 'HP:0006528', 'Chronic lung disease', 'MP:0003473', 'decreased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347991, 'HP:0006528', 'Chronic lung disease', 'MP:0010922', 'alveolitis', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347992, 'HP:0006528', 'Chronic lung disease', 'MP:0003157', 'impaired muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347993, 'HP:0006528', 'Chronic lung disease', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347994, 'HP:0006528', 'Chronic lung disease', 'MP:0001958', 'emphysema', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347995, 'HP:0006528', 'Chronic lung disease', 'MP:0020147', 'abnormal defecation amount', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347996, 'HP:0006528', 'Chronic lung disease', 'MP:0002090', 'abnormal vision', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347997, 'HP:0006528', 'Chronic lung disease', 'MP:0008697', 'decreased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347998, 'HP:0006528', 'Chronic lung disease', 'MP:0003725', 'increased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347999, 'HP:0006528', 'Chronic lung disease', 'MP:0010570', 'prolonged ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348000, 'HP:0006528', 'Chronic lung disease', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348001, 'HP:0006528', 'Chronic lung disease', 'MP:0030575', 'decreased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348002, 'HP:0006528', 'Chronic lung disease', 'MP:0020096', 'high mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348003, 'HP:0006528', 'Chronic lung disease', 'MP:0003471', 'abnormal summary potential threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348004, 'HP:0006528', 'Chronic lung disease', 'MP:0001872', 'sinus inflammation', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348005, 'HP:0006528', 'Chronic lung disease', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348006, 'HP:0006528', 'Chronic lung disease', 'MP:0002988', 'decreased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348007, 'HP:0006528', 'Chronic lung disease', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348008, 'HP:0006528', 'Chronic lung disease', 'MP:0013806', 'encephalopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348009, 'HP:0006528', 'Chronic lung disease', 'MP:0031053', 'pleuritis', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348010, 'HP:0006528', 'Chronic lung disease', 'MP:0006001', 'abnormal intestinal transit time', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348011, 'HP:0006528', 'Chronic lung disease', 'MP:0010515', 'abnormal Q wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348012, 'HP:0006528', 'Chronic lung disease', 'MP:0031090', 'ageusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348013, 'HP:0006528', 'Chronic lung disease', 'MP:0001948', 'vesicoureteral reflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348014, 'HP:0006528', 'Chronic lung disease', 'MP:0005037', 'mucous diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348015, 'HP:0006528', 'Chronic lung disease', 'MP:0003375', 'abnormal menstrual cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348016, 'HP:0006528', 'Chronic lung disease', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348017, 'HP:0006528', 'Chronic lung disease', 'MP:0009732', 'ventricular premature beat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348018, 'HP:0006528', 'Chronic lung disease', 'MP:0031222', 'decreased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348019, 'HP:0006528', 'Chronic lung disease', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348020, 'HP:0006528', 'Chronic lung disease', 'MP:0003899', 'abnormal QT interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348021, 'HP:0006528', 'Chronic lung disease', 'MP:0009350', 'decreased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348022, 'HP:0006528', 'Chronic lung disease', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348023, 'HP:0006528', 'Chronic lung disease', 'MP:0001819', 'abnormal immune cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348024, 'HP:0006528', 'Chronic lung disease', 'MP:0020138', 'delayed bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348025, 'HP:0006528', 'Chronic lung disease', 'MP:0005671', 'abnormal response to transplant', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348026, 'HP:0006528', 'Chronic lung disease', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348027, 'HP:0006528', 'Chronic lung disease', 'MP:0002409', 'decreased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348028, 'HP:0006528', 'Chronic lung disease', 'MP:0031484', 'increased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348029, 'HP:0006528', 'Chronic lung disease', 'MP:0008690', 'increased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348030, 'HP:0006528', 'Chronic lung disease', 'MP:0030132', 'periodontium inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348031, 'HP:0006528', 'Chronic lung disease', 'MP:0008703', 'decreased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348032, 'HP:0006528', 'Chronic lung disease', 'MP:0030002', 'increased lung apoptosis', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348033, 'HP:0006528', 'Chronic lung disease', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348034, 'HP:0006528', 'Chronic lung disease', 'MP:0005004', 'abnormal lymphocyte anergy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348035, 'HP:0006528', 'Chronic lung disease', 'MP:0011920', 'abnormal S wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348036, 'HP:0006528', 'Chronic lung disease', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348037, 'HP:0006528', 'Chronic lung disease', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348038, 'HP:0006528', 'Chronic lung disease', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348039, 'HP:0006528', 'Chronic lung disease', 'MP:0012555', 'decreased cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348040, 'HP:0006528', 'Chronic lung disease', 'MP:0012111', 'failure of morula compaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348041, 'HP:0006528', 'Chronic lung disease', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348042, 'HP:0006528', 'Chronic lung disease', 'MP:0008003', 'achlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348043, 'HP:0006528', 'Chronic lung disease', 'MP:0003929', 'decreased heart rate variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348044, 'HP:0006528', 'Chronic lung disease', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348045, 'HP:0006528', 'Chronic lung disease', 'MP:0000501', 'abnormal digestive secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348046, 'HP:0006528', 'Chronic lung disease', 'MP:0003566', 'abnormal cell adhesion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348047, 'HP:0006528', 'Chronic lung disease', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348048, 'HP:0006528', 'Chronic lung disease', 'MP:0009473', 'abnormal skin exfoliation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348049, 'HP:0006528', 'Chronic lung disease', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348050, 'HP:0006528', 'Chronic lung disease', 'MP:0003280', 'urinary incontinence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348051, 'HP:0006528', 'Chronic lung disease', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348052, 'HP:0006528', 'Chronic lung disease', 'MP:0008684', 'increased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348053, 'HP:0006528', 'Chronic lung disease', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348054, 'HP:0006528', 'Chronic lung disease', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348055, 'HP:0006528', 'Chronic lung disease', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348056, 'HP:0006528', 'Chronic lung disease', 'MP:0010896', 'decreased lung compliance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348057, 'HP:0006528', 'Chronic lung disease', 'MP:0020218', 'abnormal tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348058, 'HP:0006528', 'Chronic lung disease', 'MP:0031130', 'right-to-left shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348059, 'HP:0006528', 'Chronic lung disease', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348060, 'HP:0006528', 'Chronic lung disease', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348061, 'HP:0006528', 'Chronic lung disease', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348062, 'HP:0006528', 'Chronic lung disease', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348063, 'HP:0006528', 'Chronic lung disease', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348064, 'HP:0006528', 'Chronic lung disease', 'MP:0011804', 'increased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348065, 'HP:0006528', 'Chronic lung disease', 'MP:0003726', 'decreased autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348066, 'HP:0006528', 'Chronic lung disease', 'MP:0001862', 'interstitial pneumonia', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348067, 'HP:0006528', 'Chronic lung disease', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348068, 'HP:0006528', 'Chronic lung disease', 'MP:0002635', 'reduced sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348069, 'HP:0006528', 'Chronic lung disease', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348070, 'HP:0006528', 'Chronic lung disease', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348071, 'HP:0006528', 'Chronic lung disease', 'MP:0004782', 'abnormal surfactant physiology', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348072, 'HP:0006528', 'Chronic lung disease', 'MP:0008544', 'impaired olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348073, 'HP:0006528', 'Chronic lung disease', 'MP:0002314', 'abnormal respiratory mechanics', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348074, 'HP:0006528', 'Chronic lung disease', 'MP:0003256', 'biliary cirrhosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348075, 'HP:0006528', 'Chronic lung disease', 'MP:0011466', 'increased urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348076, 'HP:0006528', 'Chronic lung disease', 'MP:0010954', 'abnormal cellular respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348077, 'HP:0006528', 'Chronic lung disease', 'MP:0000947', 'convulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348078, 'HP:0006528', 'Chronic lung disease', 'MP:0008652', 'decreased interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348079, 'HP:0006528', 'Chronic lung disease', 'MP:0020844', 'abnormal pulmonary respiratory rate response', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348080, 'HP:0006528', 'Chronic lung disease', 'MP:0031470', 'abnormal macropinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348081, 'HP:0006528', 'Chronic lung disease', 'MP:0008661', 'decreased interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348082, 'HP:0006528', 'Chronic lung disease', 'MP:0008002', 'hyperchlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348083, 'HP:0006528', 'Chronic lung disease', 'MP:0020845', 'abnormal DNA-templated transcription', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348084, 'HP:0006528', 'Chronic lung disease', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348085, 'HP:0006528', 'Chronic lung disease', 'MP:0009348', 'abnormal urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348086, 'HP:0006528', 'Chronic lung disease', 'MP:0010741', 'abnormal melanocyte proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348087, 'HP:0006528', 'Chronic lung disease', 'MP:0001378', 'abnormal ejaculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348088, 'HP:0006528', 'Chronic lung disease', 'MP:0001933', 'abnormal litter size', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348089, 'HP:0006528', 'Chronic lung disease', 'MP:0031129', 'left-to-right shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348090, 'HP:0006528', 'Chronic lung disease', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348091, 'HP:0006528', 'Chronic lung disease', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348092, 'HP:0006528', 'Chronic lung disease', 'MP:0030129', 'tongue inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348093, 'HP:0006528', 'Chronic lung disease', 'MP:0002472', 'impaired complement alternative pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348094, 'HP:0006528', 'Chronic lung disease', 'MP:0004143', 'muscle hypertonia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348095, 'HP:0006528', 'Chronic lung disease', 'MP:0013136', 'genital discharge', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348096, 'HP:0006528', 'Chronic lung disease', 'MP:0011082', 'abnormal gastrointestinal motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348097, 'HP:0006528', 'Chronic lung disease', 'MP:0031091', 'hypogeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348098, 'HP:0006528', 'Chronic lung disease', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348099, 'HP:0006528', 'Chronic lung disease', 'MP:0005000', 'abnormal immune tolerance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348100, 'HP:0006528', 'Chronic lung disease', 'MP:0011047', 'increased lung tissue damping', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348101, 'HP:0006528', 'Chronic lung disease', 'MP:0005551', 'abnormal eye electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348102, 'HP:0006528', 'Chronic lung disease', 'MP:0002293', 'long gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348103, 'HP:0006528', 'Chronic lung disease', 'MP:0000313', 'abnormal cell death', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348104, 'HP:0006528', 'Chronic lung disease', 'MP:0001986', 'abnormal taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348105, 'HP:0006528', 'Chronic lung disease', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348106, 'HP:0006528', 'Chronic lung disease', 'MP:0010377', 'abnormal gut flora balance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348107, 'HP:0006528', 'Chronic lung disease', 'MP:0013134', 'poor circulation in autopods', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348108, 'HP:0006528', 'Chronic lung disease', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348109, 'HP:0006528', 'Chronic lung disease', 'MP:0030924', 'early exit from telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348110, 'HP:0006528', 'Chronic lung disease', 'MP:0013467', 'diaphragmitis', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348111, 'HP:0006528', 'Chronic lung disease', 'MP:0003926', 'decreased cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348112, 'HP:0006528', 'Chronic lung disease', 'MP:0031088', 'coughing', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348113, 'HP:0006528', 'Chronic lung disease', 'MP:0011420', 'pyuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348114, 'HP:0006528', 'Chronic lung disease', 'MP:0010504', 'abnormal RR interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348115, 'HP:0006528', 'Chronic lung disease', 'MP:0005043', 'defective assembly of class II molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348116, 'HP:0006528', 'Chronic lung disease', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348117, 'HP:0006528', 'Chronic lung disease', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348118, 'HP:0006528', 'Chronic lung disease', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348119, 'HP:0006528', 'Chronic lung disease', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348120, 'HP:0006528', 'Chronic lung disease', 'MP:0008005', 'decreased stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348121, 'HP:0006528', 'Chronic lung disease', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348122, 'HP:0006528', 'Chronic lung disease', 'MP:0004752', 'decreased length of allograft survival', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348123, 'HP:0006528', 'Chronic lung disease', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348124, 'HP:0006528', 'Chronic lung disease', 'MP:0011923', 'abnormal bladder urine volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348125, 'HP:0006528', 'Chronic lung disease', 'MP:0000948', 'nonconvulsive seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348126, 'HP:0006528', 'Chronic lung disease', 'MP:0020142', 'increased anti-sperm antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348127, 'HP:0006528', 'Chronic lung disease', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348128, 'HP:0006528', 'Chronic lung disease', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348129, 'HP:0006528', 'Chronic lung disease', 'MP:0000920', 'abnormal myelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348130, 'HP:0006528', 'Chronic lung disease', 'MP:0012197', 'impaired myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348131, 'HP:0006528', 'Chronic lung disease', 'MP:0031098', 'abnormal sputum production', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348132, 'HP:0006528', 'Chronic lung disease', 'MP:0001951', 'abnormal breathing pattern', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348133, 'HP:0006528', 'Chronic lung disease', 'MP:0003589', 'abnormal ureter physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348134, 'HP:0006528', 'Chronic lung disease', 'MP:0012554', 'increased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348135, 'HP:0006528', 'Chronic lung disease', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348136, 'HP:0006528', 'Chronic lung disease', 'MP:0010509', 'decreased P wave amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348137, 'HP:0006528', 'Chronic lung disease', 'MP:0001919', 'abnormal reproductive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348138, 'HP:0006528', 'Chronic lung disease', 'MP:0001947', 'abnormal mucociliary clearance', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348139, 'HP:0006528', 'Chronic lung disease', 'MP:0008687', 'increased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348140, 'HP:0006528', 'Chronic lung disease', 'MP:0012550', 'respiratory acidosis', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348141, 'HP:0006528', 'Chronic lung disease', 'MP:0002471', 'abnormal complement pathway', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348142, 'HP:0006528', 'Chronic lung disease', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348143, 'HP:0006528', 'Chronic lung disease', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348144, 'HP:0006528', 'Chronic lung disease', 'MP:0003470', 'abnormal summary potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348145, 'HP:0006528', 'Chronic lung disease', 'MP:0003394', 'increased cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348146, 'HP:0006528', 'Chronic lung disease', 'MP:0003465', 'increased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348147, 'HP:0006528', 'Chronic lung disease', 'MP:0004149', 'increased bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348148, 'HP:0006528', 'Chronic lung disease', 'MP:0010143', 'enhanced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348149, 'HP:0006528', 'Chronic lung disease', 'MP:0010505', 'abnormal T wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348150, 'HP:0006528', 'Chronic lung disease', 'MP:0008001', 'hypochlorhydria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348151, 'HP:0006528', 'Chronic lung disease', 'MP:0031089', 'sneezing', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348152, 'HP:0006528', 'Chronic lung disease', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348153, 'HP:0006528', 'Chronic lung disease', 'MP:0005085', 'abnormal gallbladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348154, 'HP:0006528', 'Chronic lung disease', 'MP:0030941', 'enhanced autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348155, 'HP:0006528', 'Chronic lung disease', 'MP:0011928', 'abnormal mitral valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348156, 'HP:0006528', 'Chronic lung disease', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348157, 'HP:0006528', 'Chronic lung disease', 'MP:0011718', 'decreased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348158, 'HP:0006528', 'Chronic lung disease', 'MP:0004994', 'abnormal brain wave pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348159, 'HP:0006528', 'Chronic lung disease', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348160, 'HP:0006528', 'Chronic lung disease', 'MP:0003875', 'abnormal hair follicle regression', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348161, 'HP:0006528', 'Chronic lung disease', 'MP:0003927', 'increased cellular glucose import', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348162, 'HP:0006528', 'Chronic lung disease', 'MP:0014157', 'alacrima', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348163, 'HP:0006528', 'Chronic lung disease', 'MP:0003674', 'oxidative stress', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348164, 'HP:0006528', 'Chronic lung disease', 'MP:0020040', 'decreased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348165, 'HP:0006528', 'Chronic lung disease', 'MP:0002333', 'abnormal lung compliance', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348166, 'HP:0006528', 'Chronic lung disease', 'MP:0031092', 'dysgeusia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348167, 'HP:0006528', 'Chronic lung disease', 'MP:0008696', 'increased interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348168, 'HP:0006528', 'Chronic lung disease', 'MP:0010511', 'shortened PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348169, 'HP:0006528', 'Chronic lung disease', 'MP:0011926', 'abnormal heart valve physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348170, 'HP:0006528', 'Chronic lung disease', 'MP:0010028', 'aciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348171, 'HP:0006528', 'Chronic lung disease', 'MP:0013637', 'increased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348172, 'HP:0006528', 'Chronic lung disease', 'MP:0002106', 'abnormal muscle physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348173, 'HP:0006528', 'Chronic lung disease', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348174, 'HP:0006528', 'Chronic lung disease', 'MP:0010155', 'abnormal intestine physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348175, 'HP:0006528', 'Chronic lung disease', 'MP:0008678', 'increased interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348176, 'HP:0006528', 'Chronic lung disease', 'MP:0008722', 'abnormal chemokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348177, 'HP:0006528', 'Chronic lung disease', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348178, 'HP:0006528', 'Chronic lung disease', 'MP:0008700', 'decreased interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348179, 'HP:0006528', 'Chronic lung disease', 'MP:0008260', 'abnormal autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348180, 'HP:0006528', 'Chronic lung disease', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348181, 'HP:0006528', 'Chronic lung disease', 'MP:0004070', 'abnormal P wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348182, 'HP:0006528', 'Chronic lung disease', 'MP:0003466', 'decreased single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348183, 'HP:0006528', 'Chronic lung disease', 'MP:0009697', 'abnormal copulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348184, 'HP:0006528', 'Chronic lung disease', 'MP:0011131', 'abnormal lung endothelial cell physiology', 0.42424242424242425, 8.526773851447254, 1.9019514214892284, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348185, 'HP:0006528', 'Chronic lung disease', 'MP:0002826', 'tonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348186, 'HP:0006528', 'Chronic lung disease', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348187, 'HP:0006528', 'Chronic lung disease', 'MP:0011397', 'endoneurial edema', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348188, 'HP:0006528', 'Chronic lung disease', 'MP:0008055', 'increased urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348189, 'HP:0006528', 'Chronic lung disease', 'MP:0002723', 'abnormal immune serum protein physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348190, 'HP:0006528', 'Chronic lung disease', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348191, 'HP:0006528', 'Chronic lung disease', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348192, 'HP:0006528', 'Chronic lung disease', 'MP:0000231', 'hypertension', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348193, 'HP:0006528', 'Chronic lung disease', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348194, 'HP:0006528', 'Chronic lung disease', 'MP:0006150', 'double vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348195, 'HP:0006528', 'Chronic lung disease', 'MP:0008682', 'decreased interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348196, 'HP:0006528', 'Chronic lung disease', 'MP:0000423', 'delayed hair regrowth', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348197, 'HP:0006528', 'Chronic lung disease', 'MP:0020154', 'impaired humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348198, 'HP:0006528', 'Chronic lung disease', 'MP:0005666', 'abnormal adipose tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348199, 'HP:0006528', 'Chronic lung disease', 'MP:0013127', 'epistaxis', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348200, 'HP:0006528', 'Chronic lung disease', 'MP:0031302', 'syncope', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348201, 'HP:0006528', 'Chronic lung disease', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348202, 'HP:0006528', 'Chronic lung disease', 'MP:0010386', 'abnormal urinary bladder physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348203, 'HP:0006528', 'Chronic lung disease', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348204, 'HP:0006528', 'Chronic lung disease', 'MP:0002499', 'chronic inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348205, 'HP:0006528', 'Chronic lung disease', 'MP:0006138', 'congestive heart failure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348206, 'HP:0006528', 'Chronic lung disease', 'MP:0003292', 'melena', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348207, 'HP:0006528', 'Chronic lung disease', 'MP:0004011', 'decreased diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348208, 'HP:0006528', 'Chronic lung disease', 'MP:0003260', 'vomiting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348209, 'HP:0006528', 'Chronic lung disease', 'MP:0003186', 'abnormal redox activity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348210, 'HP:0006528', 'Chronic lung disease', 'MP:0012040', 'abnormal c-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348211, 'HP:0006528', 'Chronic lung disease', 'MP:0011954', 'shortened PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348212, 'HP:0006528', 'Chronic lung disease', 'MP:0020137', 'decreased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348213, 'HP:0006528', 'Chronic lung disease', 'MP:0012200', 'increased endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348214, 'HP:0006528', 'Chronic lung disease', 'MP:0002421', 'abnormal cell-mediated immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348215, 'HP:0006528', 'Chronic lung disease', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348216, 'HP:0006528', 'Chronic lung disease', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348217, 'HP:0006528', 'Chronic lung disease', 'MP:0031402', 'decreased muscle fatigability', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348218, 'HP:0006528', 'Chronic lung disease', 'MP:0004859', 'abnormal synaptic plasticity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348219, 'HP:0006528', 'Chronic lung disease', 'MP:0001921', 'reduced fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348220, 'HP:0006528', 'Chronic lung disease', 'MP:0000427', 'abnormal hair cycle', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348221, 'HP:0006528', 'Chronic lung disease', 'MP:0013627', 'increased vertebra yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348222, 'HP:0006528', 'Chronic lung disease', 'MP:0001943', 'abnormal respiration', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348223, 'HP:0006528', 'Chronic lung disease', 'MP:0013625', 'increased femur yield load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348224, 'HP:0006528', 'Chronic lung disease', 'MP:0008670', 'decreased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348225, 'HP:0006528', 'Chronic lung disease', 'MP:0012565', 'perivasculitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348226, 'HP:0006528', 'Chronic lung disease', 'MP:0002498', 'abnormal acute inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348227, 'HP:0006528', 'Chronic lung disease', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348228, 'HP:0006528', 'Chronic lung disease', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348229, 'HP:0006528', 'Chronic lung disease', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348230, 'HP:0006528', 'Chronic lung disease', 'MP:0013753', 'tracheomalacia', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348231, 'HP:0006528', 'Chronic lung disease', 'MP:0003009', 'abnormal cytokine secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348232, 'HP:0006528', 'Chronic lung disease', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348233, 'HP:0006528', 'Chronic lung disease', 'MP:0012120', 'trophectoderm cell degeneration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348234, 'HP:0006528', 'Chronic lung disease', 'MP:0003928', 'increased heart rate variability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348235, 'HP:0006528', 'Chronic lung disease', 'MP:0008558', 'abnormal interferon-beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348236, 'HP:0006528', 'Chronic lung disease', 'MP:0008008', 'early cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348237, 'HP:0006528', 'Chronic lung disease', 'MP:0001665', 'chronic diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348238, 'HP:0006528', 'Chronic lung disease', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348239, 'HP:0006528', 'Chronic lung disease', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348240, 'HP:0006528', 'Chronic lung disease', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348241, 'HP:0006528', 'Chronic lung disease', 'MP:0013210', 'abnormal primary cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348242, 'HP:0006528', 'Chronic lung disease', 'MP:0003122', 'maternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348243, 'HP:0006528', 'Chronic lung disease', 'MP:0005532', 'abnormal vascular resistance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348244, 'HP:0006528', 'Chronic lung disease', 'MP:0002330', 'abnormal bronchial provocation', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348245, 'HP:0006528', 'Chronic lung disease', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348246, 'HP:0006528', 'Chronic lung disease', 'MP:0031306', 'abnormal cartilage physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348247, 'HP:0006528', 'Chronic lung disease', 'MP:0004142', 'abnormal muscle tone', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348248, 'HP:0006528', 'Chronic lung disease', 'MP:0006388', 'abnormal auditory summating potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348249, 'HP:0006528', 'Chronic lung disease', 'MP:0009668', 'ectopic pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348250, 'HP:0006528', 'Chronic lung disease', 'MP:0013475', 'delayed reproductive senescence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348251, 'HP:0006528', 'Chronic lung disease', 'MP:0002693', 'abnormal pancreas physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348252, 'HP:0006528', 'Chronic lung disease', 'MP:0000505', 'decreased digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348253, 'HP:0006528', 'Chronic lung disease', 'MP:0010334', 'pleural effusion', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348254, 'HP:0006528', 'Chronic lung disease', 'MP:0013636', 'abnormal bone stiffness', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348255, 'HP:0006528', 'Chronic lung disease', 'MP:0013640', 'increased bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348256, 'HP:0006528', 'Chronic lung disease', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348257, 'HP:0006528', 'Chronic lung disease', 'MP:0006042', 'increased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348258, 'HP:0006528', 'Chronic lung disease', 'MP:0008406', 'increased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348259, 'HP:0006528', 'Chronic lung disease', 'MP:0003472', 'increased summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348260, 'HP:0006528', 'Chronic lung disease', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348261, 'HP:0006528', 'Chronic lung disease', 'MP:0008950', 'ventricular tachycardia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348262, 'HP:0006528', 'Chronic lung disease', 'MP:0031125', 'aspiration pneumonia', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(348263, 'HP:0006528', 'Chronic lung disease', 'MP:0002796', 'impaired skin barrier function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348264, 'HP:0006528', 'Chronic lung disease', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348265, 'HP:0006528', 'Chronic lung disease', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348266, 'HP:0006528', 'Chronic lung disease', 'MP:0014132', 'abnormal tear film physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348267, 'HP:0006528', 'Chronic lung disease', 'MP:0004766', 'decreased susceptibility to age-related hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348268, 'HP:0006528', 'Chronic lung disease', 'MP:0006046', 'atrioventricular valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348269, 'HP:0006528', 'Chronic lung disease', 'MP:0008669', 'increased interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348270, 'HP:0006528', 'Chronic lung disease', 'MP:0011417', 'abnormal renal transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348271, 'HP:0006528', 'Chronic lung disease', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348272, 'HP:0020206', 'Simple ear', 'MP:0020290', 'floppy ears', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348273, 'HP:0020206', 'Simple ear', 'MP:0030092', 'abnormal outer ear helix morphology', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348274, 'HP:0020206', 'Simple ear', 'MP:0003713', 'abnormal ear rotation', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348275, 'HP:0020206', 'Simple ear', 'MP:0003677', 'abnormal ear lobe morphology', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348276, 'HP:0020206', 'Simple ear', 'MP:0003716', 'anteriorly rotated ears', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348277, 'HP:0020206', 'Simple ear', 'MP:0000053', 'excessive ear growth', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348278, 'HP:0020206', 'Simple ear', 'MP:0003736', 'folded helix', 0.46296296296296297, 11.115294171581601, 2.268472949779294, 'UPHENO:0005986', 'abnormal shape of external ear'),
(348279, 'HP:0020206', 'Simple ear', 'MP:0000018', 'small ears', 0.44680851063829785, 10.255471829629862, 2.1406148869168264, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348280, 'HP:0020206', 'Simple ear', 'MP:0003735', 'cup-shaped ears', 0.5102040816326531, 11.115294171581601, 2.381400523828063, 'UPHENO:0005986', 'abnormal shape of external ear'),
(348281, 'HP:0020206', 'Simple ear', 'MP:0003715', 'posteriorly rotated ears', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348282, 'HP:0020206', 'Simple ear', 'MP:0000023', 'abnormal ear position', 0.41304347826086957, 10.255471829629862, 2.0581437645890244, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348283, 'HP:0020206', 'Simple ear', 'MP:0003737', 'ossification of pinnae', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348284, 'HP:0020206', 'Simple ear', 'MP:0030074', 'coarse facial features', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348285, 'HP:0020206', 'Simple ear', 'MP:0000019', 'thick ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348286, 'HP:0020206', 'Simple ear', 'MP:0000017', 'big ears', 0.44680851063829785, 10.255471829629862, 2.1406148869168264, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348287, 'HP:0020206', 'Simple ear', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(348288, 'HP:0020206', 'Simple ear', 'MP:0003681', 'protruding ear lobes', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348289, 'HP:0020206', 'Simple ear', 'MP:0030078', 'synotia', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348290, 'HP:0020206', 'Simple ear', 'MP:0003712', 'raised ear position', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348291, 'HP:0020206', 'Simple ear', 'MP:0030045', 'abnormal forehead shape', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348292, 'HP:0020206', 'Simple ear', 'MP:0000020', 'scaly ears', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348293, 'HP:0020206', 'Simple ear', 'MP:0030368', 'trigonocephaly', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348294, 'HP:0020206', 'Simple ear', 'MP:0030071', 'abnormal face shape', 0.43478260869565216, 6.5236679405794336, 1.684154792609432, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348295, 'HP:0020206', 'Simple ear', 'MP:0000022', 'abnormal ear shape', 0.5813953488372093, 11.115294171581601, 2.542121226911668, 'UPHENO:0005986', 'abnormal shape of external ear'),
(348296, 'HP:0020206', 'Simple ear', 'MP:0020085', 'long ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348297, 'HP:0020206', 'Simple ear', 'MP:0020084', 'short ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348298, 'HP:0020206', 'Simple ear', 'MP:0002177', 'abnormal outer ear morphology', 0.42857142857142855, 10.255471829629862, 2.0964737567397576, 'UPHENO:0086699', 'abnormal external ear morphology'),
(348299, 'HP:0020206', 'Simple ear', 'MP:0009578', 'otocephaly', 0.46511627906976744, 6.5236679405794336, 1.7419139354196116, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348300, 'HP:0020206', 'Simple ear', 'MP:0011495', 'abnormal head shape', 0.47619047619047616, 6.5236679405794336, 1.7625290190896328, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348301, 'HP:0020206', 'Simple ear', 'MP:0006290', 'proboscis', 0.46511627906976744, 6.5236679405794336, 1.7419139354196116, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(348302, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348303, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348304, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348305, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348306, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0003939', 'abnormal myotome morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348307, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0000733', 'abnormal muscle development', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348308, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0000767', 'abnormal smooth muscle morphology', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348309, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348310, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0004818', 'increased skeletal muscle mass', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348311, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0013857', 'abnormal abdominal muscle morphology', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348312, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0000752', 'dystrophic muscle', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348313, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348314, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348315, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348316, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348317, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0003199', 'calcified muscle', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348318, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0004817', 'abnormal skeletal muscle mass', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348319, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0000736', 'delayed muscle development', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348320, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348321, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0004233', 'abnormal muscle weight', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348322, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0009407', 'increased skeletal muscle fiber density', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348323, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348324, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348325, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0002108', 'abnormal muscle morphology', 0.5217391304347826, 7.206267831629091, 1.9390182856678553, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348326, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348327, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348328, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0000731', 'increased collagen deposition in the muscles', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348329, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(348330, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0031112', 'rhabdomyolysis', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348331, 'HP:0034370', 'Abnormal muscle tissue metabolite concentration', 'MP:0004819', 'decreased skeletal muscle mass', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(348332, 'HP:0003031', 'Ulnar bowing', 'MP:0004361', 'bowed ulna', 0.6236559139784946, 16.607147267911277, 3.218251949109123, 'UPHENO:0031149', 'abnormal ulna, increased curvature'),
(348333, 'HP:0003031', 'Ulnar bowing', 'MP:0004373', 'bowed humerus', 0.44660194174757284, 12.083585311854263, 2.3230481406003114, 'UPHENO:0082475', 'increased curvature anatomical entity in independent continuant'),
(348334, 'HP:0003031', 'Ulnar bowing', 'MP:0004374', 'bowed radius', 0.5306122448979592, 14.732678149995134, 2.7959505407871634, 'UPHENO:0041344', 'increased curvature forelimb zeugopod bone'),
(348335, 'HP:0004990', 'Epiphyseal streaking', 'MP:0000131', 'abnormal long bone epiphysis morphology', 0.40540540540540543, 7.953705029307353, 1.795682324878585, 'UPHENO:0087487', 'abnormal epiphysis morphology'),
(348336, 'HP:0004990', 'Epiphyseal streaking', 'MP:0004686', 'decreased length of long bones', 0.4186046511627907, 6.930014923262251, 1.7032135742487284, 'UPHENO:0020041', 'abnormal long bone morphology'),
(348337, 'HP:0004990', 'Epiphyseal streaking', 'MP:0006322', 'abnormal perichondrium morphology', 0.40540540540540543, 4.825104621810128, 1.3986148488159384, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(348338, 'HP:0004990', 'Epiphyseal streaking', 'MP:0000132', 'thickened long bone epiphysis', 0.425531914893617, 8.003520922925084, 1.8454683915536023, 'UPHENO:0020832', 'abnormal epiphysis morphology'),
(348339, 'HP:0004990', 'Epiphyseal streaking', 'MP:0004695', 'increased length of long bones', 0.4186046511627907, 6.930014923262251, 1.7032135742487284, 'UPHENO:0020041', 'abnormal long bone morphology'),
(348340, 'HP:0004990', 'Epiphyseal streaking', 'MP:0008910', 'thin long bone epiphysis', 0.43478260869565216, 8.003520922925084, 1.865419981028294, 'UPHENO:0020832', 'abnormal epiphysis morphology'),
(348341, 'HP:0010813', 'Abnormal number of hair whorls', 'MP:0009270', 'abnormal guard hair length', 0.4074074074074074, 9.944182255188846, 2.012792466046421, 'UPHENO:0075677', 'abnormal strand of hair'),
(348342, 'HP:0010813', 'Abnormal number of hair whorls', 'MP:0010142', 'disorganized hair shaft', 0.43137254901960786, 9.944182255188846, 2.071146360674775, 'UPHENO:0075677', 'abnormal strand of hair'),
(348343, 'HP:0010813', 'Abnormal number of hair whorls', 'MP:0013112', 'greasy thorax coat', 0.41509433962264153, 9.944182255188846, 2.031692340465161, 'UPHENO:0075677', 'abnormal strand of hair'),
(348344, 'HP:0010813', 'Abnormal number of hair whorls', 'MP:0013111', 'greasy abdomen coat', 0.41509433962264153, 9.944182255188846, 2.031692340465161, 'UPHENO:0075677', 'abnormal strand of hair'),
(348345, 'HP:0010813', 'Abnormal number of hair whorls', 'MP:0000384', 'distorted hair follicle pattern', 0.40816326530612246, 9.74502654242278, 1.9943825746456256, 'UPHENO:0086475', 'abnormal pilosebaceous unit morphology'),
(348346, 'HP:0010813', 'Abnormal number of hair whorls', 'MP:0003849', 'greasy coat', 0.4230769230769231, 9.944182255188846, 2.0511348154232656, 'UPHENO:0075677', 'abnormal strand of hair'),
(348347, 'HP:0012163', 'Carotid artery dilatation', 'MP:0003437', 'abnormal carotid body morphology', 0.40476190476190477, 11.249595263293193, 2.1338715065746237, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(348348, 'HP:0012163', 'Carotid artery dilatation', 'MP:0011655', 'abnormal systemic artery morphology', 0.42105263157894735, 9.101997348968142, 1.9576567463188328, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(348349, 'HP:0012163', 'Carotid artery dilatation', 'MP:0012729', 'abnormal common carotid artery morphology', 0.40476190476190477, 11.249595263293193, 2.1338715065746237, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(348350, 'HP:0012163', 'Carotid artery dilatation', 'MP:0004938', 'dilated vasculature', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(348351, 'HP:0012163', 'Carotid artery dilatation', 'MP:0010522', 'calcified aorta', 0.40425531914893614, 9.101997348968142, 1.9182103229833498, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(348352, 'HP:0012163', 'Carotid artery dilatation', 'MP:0020841', 'abnormal supporting cell of carotid body morphology', 0.40816326530612246, 11.249595263293193, 2.1428185961574155, 'UPHENO:0076798', 'abnormal common carotid artery plus branches morphology'),
(348353, 'HP:0012163', 'Carotid artery dilatation', 'MP:0006133', 'calcified artery', 0.43902439024390244, 8.259895016664046, 1.9042834277411493, 'UPHENO:0086797', 'abnormal artery morphology'),
(348354, 'HP:0012163', 'Carotid artery dilatation', 'MP:0002191', 'abnormal artery morphology', 0.40540540540540543, 8.259895016664046, 1.8299196943682463, 'UPHENO:0086797', 'abnormal artery morphology'),
(348355, 'HP:0012163', 'Carotid artery dilatation', 'MP:0012562', 'blood vessel degeneration', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(348356, 'HP:0012163', 'Carotid artery dilatation', 'MP:0020327', 'abnormal capillary branching pattern', 0.40476190476190477, 6.970522647367627, 1.6797029570535724, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(348357, 'HP:0012163', 'Carotid artery dilatation', 'MP:0000265', 'blood vessel atresia', 0.425, 6.970522647367627, 1.7211833502364706, 'UPHENO:0087186', 'abnormal blood vessel morphology'),
(348358, 'HP:0012163', 'Carotid artery dilatation', 'MP:0006134', 'artery occlusion', 0.4186046511627907, 8.259895016664046, 1.8594704816403853, 'UPHENO:0086797', 'abnormal artery morphology'),
(348359, 'HP:0012163', 'Carotid artery dilatation', 'MP:0013982', 'inverse situs of great intrathoracic arteries', 0.41025641025641024, 9.101997348968142, 1.9323956009448564, 'UPHENO:0087334', 'abnormal systemic artery morphology'),
(348360, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0008069', 'abnormal joint mobility', 0.4411764705882353, 12.04236264912775, 2.3049527220933994, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(348361, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0008271', 'abnormal bone ossification', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348362, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0030797', 'joint laxity', 0.42857142857142855, 12.04236264912775, 2.2717862055906344, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(348363, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0030863', 'decreased joint mobility', 0.40540540540540543, 12.04236264912775, 2.2095336412484303, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(348364, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0002998', 'abnormal bone remodeling', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348365, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0013636', 'abnormal bone stiffness', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348366, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0030798', 'joint contracture', 0.42857142857142855, 12.04236264912775, 2.2717862055906344, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(348367, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0001542', 'abnormal bone strength', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348368, 'HP:0005639', 'Hyperextensible hand joints', 'MP:0001533', 'abnormal skeleton physiology', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348369, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348370, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348371, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348372, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348373, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348374, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348375, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348376, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348377, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348378, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348379, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348380, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348381, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348382, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348383, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348384, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348385, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348386, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348387, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348388, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348389, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348390, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348391, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348392, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348393, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348394, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348395, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348396, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348397, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348398, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348399, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348400, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348401, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348402, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348403, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348404, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348405, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348406, 'HP:0034243', 'Abnormal fetal pulmonary morphology', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(348407, 'HP:0000337', 'Broad forehead', 'MP:0030069', 'broad face', 0.48, 9.252530554317739, 2.1074189583641205, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(348408, 'HP:0000337', 'Broad forehead', 'MP:0013396', 'eyelid hyperplasia', 0.4230769230769231, 5.9605885577567275, 1.5880136859433016, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348409, 'HP:0000337', 'Broad forehead', 'MP:0001296', 'macrophthalmia', 0.4230769230769231, 5.9605885577567275, 1.5880136859433016, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348410, 'HP:0000337', 'Broad forehead', 'MP:0030031', 'abnormal forehead morphology', 0.4090909090909091, 12.982656403003482, 2.304579508352794, 'UPHENO:0076704', 'abnormal forehead morphology'),
(348411, 'HP:0000337', 'Broad forehead', 'MP:0030063', 'abnormal face size', 0.43478260869565216, 5.913369942082322, 1.603443297906418, 'UPHENO:0087472', 'abnormal face morphology'),
(348412, 'HP:0000337', 'Broad forehead', 'MP:0000346', 'broad head', 0.4074074074074074, 9.252530554317739, 1.94153276693761, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(348413, 'HP:0000337', 'Broad forehead', 'MP:0030068', 'large face', 0.4583333333333333, 5.9605885577567275, 1.65285704835753, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348414, 'HP:0000337', 'Broad forehead', 'MP:0001305', 'enlarged lens', 0.4074074074074074, 5.9605885577567275, 1.5583285696341211, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348415, 'HP:0000337', 'Broad forehead', 'MP:0000446', 'long snout', 0.4230769230769231, 5.9605885577567275, 1.5880136859433016, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348416, 'HP:0000337', 'Broad forehead', 'MP:0030251', 'broad frontonasal prominence', 0.44, 9.252530554317739, 2.0177000381374346, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(348417, 'HP:0000337', 'Broad forehead', 'MP:0030044', 'short forehead', 0.4339622641509434, 14.104646927382092, 2.474042141042949, 'UPHENO:0075165', 'abnormal size of forehead'),
(348418, 'HP:0000337', 'Broad forehead', 'MP:0030042', 'large forehead', 0.5652173913043478, 15.192109768632433, 2.9303318330584545, 'UPHENO:0001452', 'increased size of the forehead'),
(348419, 'HP:0000337', 'Broad forehead', 'MP:0030032', 'high forehead', 0.5098039215686274, 15.192109768632433, 2.7829834956301602, 'UPHENO:0001452', 'increased size of the forehead'),
(348420, 'HP:0000337', 'Broad forehead', 'MP:0009274', 'buphthalmos', 0.41509433962264153, 5.9605885577567275, 1.5729610837984207, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348421, 'HP:0000337', 'Broad forehead', 'MP:0006162', 'thick eyelids', 0.4074074074074074, 5.9605885577567275, 1.5583285696341211, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348422, 'HP:0000337', 'Broad forehead', 'MP:0030041', 'abnormal forehead size', 0.5111111111111111, 14.104646927382092, 2.6849658774152383, 'UPHENO:0075165', 'abnormal size of forehead'),
(348423, 'HP:0000337', 'Broad forehead', 'MP:0000434', 'megacephaly', 0.43478260869565216, 5.9605885577567275, 1.6098323647209123, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348424, 'HP:0000337', 'Broad forehead', 'MP:0020302', 'large horns', 0.43478260869565216, 5.9605885577567275, 1.6098323647209123, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348425, 'HP:0000337', 'Broad forehead', 'MP:0030045', 'abnormal forehead shape', 0.42, 12.982656403003482, 2.3351050702830185, 'UPHENO:0076704', 'abnormal forehead morphology'),
(348426, 'HP:0000337', 'Broad forehead', 'MP:0030070', 'long face', 0.41509433962264153, 5.9605885577567275, 1.5729610837984207, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(348427, 'HP:0000337', 'Broad forehead', 'MP:0011496', 'abnormal head size', 0.4090909090909091, 4.6730878730104815, 1.382648822453323, 'UPHENO:0087907', 'abnormal head morphology'),
(348428, 'HP:0000337', 'Broad forehead', 'MP:0030043', 'small forehead', 0.46938775510204084, 14.104646927382092, 2.573042665357646, 'UPHENO:0075165', 'abnormal size of forehead'),
(348429, 'HP:0000337', 'Broad forehead', 'MP:0000449', 'broad nasal bridge', 0.41379310344827586, 9.252530554317739, 1.9566893807707786, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(348430, 'HP:0000337', 'Broad forehead', 'MP:0030189', 'broad snout', 0.4897959183673469, 9.252530554317739, 2.128814623229086, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(348431, 'HP:0000337', 'Broad forehead', 'MP:0003759', 'broad palate', 0.41379310344827586, 9.252530554317739, 1.9566893807707786, 'UPHENO:0081800', 'increased width of the anatomical entity in independent continuant'),
(348432, 'HP:0001269', 'Hemiparesis', 'MP:0004768', 'abnormal axonal transport', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348433, 'HP:0001269', 'Hemiparesis', 'MP:0021001', 'impaired neuron physiology', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348434, 'HP:0001269', 'Hemiparesis', 'MP:0010654', 'slow Wallerian degeneration', 0.40476190476190477, 11.437222266468964, 2.151592868030857, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348435, 'HP:0001269', 'Hemiparesis', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348436, 'HP:0001269', 'Hemiparesis', 'MP:0009967', 'abnormal neuron proliferation', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348437, 'HP:0001269', 'Hemiparesis', 'MP:0003202', 'abnormal neuron apoptosis', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348438, 'HP:0001269', 'Hemiparesis', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348439, 'HP:0001269', 'Hemiparesis', 'MP:0004811', 'abnormal neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348440, 'HP:0001269', 'Hemiparesis', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(348441, 'HP:0004482', 'Relative macrocephaly', 'MP:0000439', 'enlarged cranium', 0.42105263157894735, 7.173214147510782, 1.7379012324320247, 'UPHENO:0081566', 'abnormal skull morphology'),
(348442, 'HP:0004482', 'Relative macrocephaly', 'MP:0000434', 'megacephaly', 0.4583333333333333, 13.87018167374507, 2.5213422220052735, 'UPHENO:0001208', 'increased size of the head'),
(348443, 'HP:0004482', 'Relative macrocephaly', 'MP:0030287', 'enlarged occipital bone', 0.4067796610169492, 7.173214147510782, 1.7081913298358646, 'UPHENO:0081566', 'abnormal skull morphology'),
(348444, 'HP:0004482', 'Relative macrocephaly', 'MP:0030316', 'enlarged neurocranium', 0.42105263157894735, 7.173214147510782, 1.7379012324320247, 'UPHENO:0081566', 'abnormal skull morphology'),
(348445, 'HP:0004482', 'Relative macrocephaly', 'MP:0011496', 'abnormal head size', 0.40425531914893614, 12.66854781257542, 2.263035094541451, 'UPHENO:0075148', 'abnormal size of head'),
(348446, 'HP:0033985', 'Elongated femoral neck', 'MP:0030827', 'femur fracture', 0.4444444444444444, 11.359219754467691, 2.246896106431437, 'UPHENO:0020967', 'abnormal femur morphology'),
(348447, 'HP:0033985', 'Elongated femoral neck', 'MP:0030794', 'broad femur neck', 0.42857142857142855, 14.022184767190119, 2.451429737391466, 'UPHENO:0081602', 'abnormal neck of femur morphology'),
(348448, 'HP:0033985', 'Elongated femoral neck', 'MP:0008158', 'increased diameter of femur', 0.4266666666666667, 11.359219754467691, 2.201499586321306, 'UPHENO:0020967', 'abnormal femur morphology'),
(348449, 'HP:0033985', 'Elongated femoral neck', 'MP:0008152', 'decreased diameter of femur', 0.4266666666666667, 11.359219754467691, 2.201499586321306, 'UPHENO:0020967', 'abnormal femur morphology'),
(348450, 'HP:0033985', 'Elongated femoral neck', 'MP:0030793', 'short femur neck', 0.4230769230769231, 14.022184767190119, 2.4356647524072144, 'UPHENO:0081602', 'abnormal neck of femur morphology'),
(348451, 'HP:0033985', 'Elongated femoral neck', 'MP:0030825', 'decreased femur size', 0.4383561643835616, 11.359219754467691, 2.2314533385124684, 'UPHENO:0020967', 'abnormal femur morphology'),
(348452, 'HP:0033985', 'Elongated femoral neck', 'MP:0030823', 'increased femur size', 0.4383561643835616, 11.359219754467691, 2.2314533385124684, 'UPHENO:0020967', 'abnormal femur morphology'),
(348453, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348454, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348455, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348456, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0002965', 'increased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348457, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348458, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348459, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020984', 'decreased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348460, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031079', 'increased circulating troponin I level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348461, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348462, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348463, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348464, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348465, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348466, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348467, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012621', 'decreased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348468, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005567', 'decreased circulating total protein level', 0.42857142857142855, 9.555485148088783, 2.023662007502606, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348469, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0001560', 'abnormal circulating insulin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348470, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011890', 'increased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348471, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020255', 'absent circulating factor XII protein', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348472, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348473, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348474, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348475, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031077', 'increased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348476, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348477, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348478, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020985', 'increased circulating factor XI level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348479, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348480, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348481, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348482, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011887', 'decreased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348483, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348484, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348485, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348486, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005667', 'abnormal circulating leptin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348487, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0003349', 'abnormal circulating renin level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348488, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348489, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031059', 'increased circulating C-reactive protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348490, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348491, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348492, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011893', 'increased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348493, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348494, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348495, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010210', 'abnormal circulating cytokine level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348496, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348497, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348498, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348499, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348500, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348501, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348502, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348503, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348504, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348505, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348506, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348507, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011886', 'increased circulating lipase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348508, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348509, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348510, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348511, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348512, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348513, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348514, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348515, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348516, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012615', 'decreased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348517, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348518, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348519, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0004730', 'abnormal circulating gastrin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348520, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348521, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005416', 'abnormal circulating protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348522, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348523, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348524, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005419', 'decreased circulating serum albumin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348525, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348526, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010090', 'increased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348527, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348528, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348529, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348530, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348531, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348532, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0030624', 'abnormal circulating cysteine level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348533, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010215', 'abnormal circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348534, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348535, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031078', 'increased circulating troponin T level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348536, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348537, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012616', 'increased circulating factor IX level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348538, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348539, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348540, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348541, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012331', 'increased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348542, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0013256', 'increased circulating thrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348543, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348544, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348545, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(348546, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0008805', 'decreased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348547, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348548, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348549, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348550, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348551, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348552, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020258', 'decreased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348553, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010091', 'decreased circulating creatine kinase level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348554, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4634146341463415, 8.001050554100775, 1.9255658688590722, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348555, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348556, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348557, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0030745', 'increased circulating homocitrulline level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348558, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012619', 'increased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348559, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348560, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348561, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348562, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0002695', 'abnormal circulating glucagon level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348563, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348564, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348565, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348566, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348567, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348568, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348569, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012330', 'decreased circulating fibrinogen level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348570, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348571, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348572, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348573, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348574, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348575, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348576, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020257', 'increased circulating factor XII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348577, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012618', 'decreased circulating factor X level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348578, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012622', 'increased circulating factor XIII level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348579, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348580, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348581, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348582, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020248', 'decreased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348583, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(348584, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020247', 'increased circulating arginase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348585, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348586, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348587, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348588, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0008806', 'increased circulating amylase level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348589, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348590, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348591, 'HP:0033307', 'Increased circulating fetuin A concentration', 'MP:0031076', 'decreased circulating troponin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(348592, 'HP:0005086', 'Knee osteoarthritis', 'MP:0030881', 'abnormal knee morphology', 0.41025641025641024, 12.214829845132515, 2.238573707555087, 'UPHENO:0087462', 'abnormal knee morphology'),
(348593, 'HP:0006977', 'Deficit in grammar', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348594, 'HP:0006977', 'Deficit in grammar', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348595, 'HP:0006977', 'Deficit in grammar', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348596, 'HP:0006977', 'Deficit in grammar', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348597, 'HP:0006977', 'Deficit in grammar', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348598, 'HP:0006977', 'Deficit in grammar', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348599, 'HP:0006977', 'Deficit in grammar', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348600, 'HP:0006977', 'Deficit in grammar', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348601, 'HP:0006977', 'Deficit in grammar', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348602, 'HP:0006977', 'Deficit in grammar', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348603, 'HP:0006977', 'Deficit in grammar', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348604, 'HP:0006977', 'Deficit in grammar', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348605, 'HP:0006977', 'Deficit in grammar', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348606, 'HP:0006977', 'Deficit in grammar', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348607, 'HP:0006977', 'Deficit in grammar', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348608, 'HP:0006977', 'Deficit in grammar', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348609, 'HP:0006977', 'Deficit in grammar', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348610, 'HP:0006977', 'Deficit in grammar', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348611, 'HP:0006977', 'Deficit in grammar', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348612, 'HP:0006977', 'Deficit in grammar', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348613, 'HP:0006977', 'Deficit in grammar', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348614, 'HP:0006977', 'Deficit in grammar', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348615, 'HP:0006977', 'Deficit in grammar', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348616, 'HP:0006977', 'Deficit in grammar', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348617, 'HP:0006977', 'Deficit in grammar', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348618, 'HP:0006977', 'Deficit in grammar', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348619, 'HP:0006977', 'Deficit in grammar', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348620, 'HP:0006977', 'Deficit in grammar', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348621, 'HP:0006977', 'Deficit in grammar', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348622, 'HP:0006977', 'Deficit in grammar', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348623, 'HP:0006977', 'Deficit in grammar', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348624, 'HP:0006977', 'Deficit in grammar', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348625, 'HP:0006977', 'Deficit in grammar', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348626, 'HP:0006977', 'Deficit in grammar', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348627, 'HP:0006977', 'Deficit in grammar', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348628, 'HP:0006977', 'Deficit in grammar', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348629, 'HP:0006977', 'Deficit in grammar', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348630, 'HP:0006977', 'Deficit in grammar', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348631, 'HP:0006977', 'Deficit in grammar', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348632, 'HP:0006977', 'Deficit in grammar', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348633, 'HP:0006977', 'Deficit in grammar', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348634, 'HP:0006977', 'Deficit in grammar', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348635, 'HP:0006977', 'Deficit in grammar', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348636, 'HP:0006977', 'Deficit in grammar', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348637, 'HP:0006977', 'Deficit in grammar', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(348638, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348639, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348640, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348641, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348642, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348643, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348644, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348645, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348646, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348647, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348648, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348649, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348650, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348651, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348652, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348653, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348654, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348655, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348656, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348657, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348658, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348659, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348660, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348661, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348662, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348663, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348664, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348665, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348666, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348667, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348668, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348669, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348670, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348671, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348672, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348673, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348674, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348675, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348676, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348677, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348678, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348679, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348680, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348681, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348682, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348683, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348684, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348685, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348686, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348687, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348688, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348689, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348690, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348691, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348692, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348693, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348694, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348695, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348696, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348697, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348698, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348699, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348700, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348701, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348702, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348703, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348704, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348705, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348706, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348707, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348708, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348709, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348710, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348711, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348712, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348713, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348714, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348715, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348716, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348717, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348718, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348719, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348720, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348721, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348722, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348723, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348724, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348725, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348726, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348727, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348728, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348729, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348730, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348731, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348732, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348733, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348734, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348735, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348736, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348737, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348738, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348739, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348740, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348741, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348742, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348743, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348744, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348745, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348746, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348747, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348748, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348749, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348750, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348751, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348752, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348753, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348754, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348755, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348756, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348757, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348758, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348759, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348760, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348761, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348762, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348763, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348764, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348765, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348766, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348767, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348768, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348769, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348770, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348771, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348772, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348773, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348774, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348775, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348776, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348777, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348778, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348779, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348780, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348781, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348782, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348783, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348784, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348785, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348786, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348787, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348788, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348789, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348790, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348791, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348792, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348793, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348794, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348795, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348796, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348797, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348798, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348799, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348800, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348801, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348802, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348803, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348804, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348805, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348806, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348807, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348808, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348809, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348810, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348811, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348812, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348813, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348814, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348815, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348816, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348817, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348818, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348819, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348820, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348821, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348822, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348823, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348824, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348825, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348826, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348827, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348828, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348829, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348830, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348831, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348832, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348833, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348834, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348835, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348836, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348837, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348838, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348839, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348840, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348841, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348842, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348843, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348844, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348845, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348846, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348847, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348848, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348849, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348850, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348851, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348852, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348853, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348854, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348855, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348856, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348857, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348858, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348859, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348860, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348861, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348862, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348863, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348864, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348865, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348866, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348867, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348868, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348869, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348870, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348871, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348872, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348873, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348874, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348875, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348876, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348877, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348878, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348879, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348880, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348881, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348882, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348883, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348884, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348885, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348886, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348887, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348888, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348889, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348890, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348891, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348892, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348893, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348894, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348895, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348896, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348897, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348898, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348899, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348900, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348901, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348902, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348903, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348904, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348905, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348906, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348907, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348908, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348909, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348910, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348911, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348912, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348913, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348914, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348915, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348916, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348917, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348918, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348919, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348920, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348921, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348922, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348923, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348924, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348925, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348926, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348927, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348928, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348929, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348930, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348931, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348932, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348933, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348934, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348935, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348936, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348937, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348938, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348939, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348940, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348941, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348942, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348943, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348944, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348945, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348946, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348947, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348948, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348949, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348950, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348951, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348952, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348953, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348954, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348955, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348956, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348957, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348958, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348959, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348960, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348961, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348962, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348963, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348964, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348965, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348966, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348967, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348968, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348969, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348970, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348971, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348972, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348973, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348974, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348975, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348976, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348977, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348978, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348979, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348980, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348981, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348982, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348983, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348984, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348985, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348986, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348987, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348988, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348989, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348990, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348991, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348992, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348993, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348994, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348995, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348996, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348997, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(348998, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(348999, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349000, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349001, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349002, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349003, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349004, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349005, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349006, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349007, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349008, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349009, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349010, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349011, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349012, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349013, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349014, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349015, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349016, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349017, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349018, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349019, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349020, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349021, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349022, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349023, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349024, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349025, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349026, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349027, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349028, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349029, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349030, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349031, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349032, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349033, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349034, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349035, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349036, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349037, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349038, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349039, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349040, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349041, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349042, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349043, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349044, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349045, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349046, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349047, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349048, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349049, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349050, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349051, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349052, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349053, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349054, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349055, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349056, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349057, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349058, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349059, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349060, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349061, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349062, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349063, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349064, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349065, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349066, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349067, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349068, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349069, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349070, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349071, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349072, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349073, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349074, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349075, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349076, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349077, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349078, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349079, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349080, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349081, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349082, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349083, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349084, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349085, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349086, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349087, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349088, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349089, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349090, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349091, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349092, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349093, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349094, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349095, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349096, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349097, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349098, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349099, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349100, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349101, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349102, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349103, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349104, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349105, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349106, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349107, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349108, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349109, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349110, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349111, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349112, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349113, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349114, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349115, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349116, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349117, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349118, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349119, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349120, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349121, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349122, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349123, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349124, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349125, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349126, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349127, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349128, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349129, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349130, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349131, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349132, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349133, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349134, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349135, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349136, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349137, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349138, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349139, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349140, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349141, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349142, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349143, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349144, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349145, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349146, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349147, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349148, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349149, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349150, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349151, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349152, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349153, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349154, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349155, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349156, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349157, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349158, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349159, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349160, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349161, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349162, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349163, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349164, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349165, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349166, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349167, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349168, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349169, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349170, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349171, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349172, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349173, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349174, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349175, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349176, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349177, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349178, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349179, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349180, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349181, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349182, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349183, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349184, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349185, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349186, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349187, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349188, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349189, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349190, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349191, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349192, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349193, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349194, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349195, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349196, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349197, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349198, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349199, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349200, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349201, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349202, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349203, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349204, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349205, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349206, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349207, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349208, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349209, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349210, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349211, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349212, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349213, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349214, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349215, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349216, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349217, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349218, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349219, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349220, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349221, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349222, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349223, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349224, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349225, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349226, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349227, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349228, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349229, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349230, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349231, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349232, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349233, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349234, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349235, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349236, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349237, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349238, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349239, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349240, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349241, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349242, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349243, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349244, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349245, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349246, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349247, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349248, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349249, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349250, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349251, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349252, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349253, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349254, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349255, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349256, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349257, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349258, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349259, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349260, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349261, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349262, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349263, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349264, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349265, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349266, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349267, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349268, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349269, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349270, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349271, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349272, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349273, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349274, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349275, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349276, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349277, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349278, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349279, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349280, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349281, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349282, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349283, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349284, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349285, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349286, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349287, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349288, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349289, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349290, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349291, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349292, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349293, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349294, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349295, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349296, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349297, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349298, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349299, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349300, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349301, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349302, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349303, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349304, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349305, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349306, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349307, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349308, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349309, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349310, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349311, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349312, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349313, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349314, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349315, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349316, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349317, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349318, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349319, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349320, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349321, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349322, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349323, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349324, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349325, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349326, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349327, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349328, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349329, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349330, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349331, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349332, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349333, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349334, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349335, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349336, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349337, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349338, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349339, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349340, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349341, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349342, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349343, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349344, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349345, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349346, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349347, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349348, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349349, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349350, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349351, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349352, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349353, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349354, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349355, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349356, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349357, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349358, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349359, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349360, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349361, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349362, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349363, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349364, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349365, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349366, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349367, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349368, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349369, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349370, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349371, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349372, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349373, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349374, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349375, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349376, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349377, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349378, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349379, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349380, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349381, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349382, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349383, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349384, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349385, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349386, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349387, 'HP:0034002', 'Anti-phospholipase A2 receptor antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349388, 'HP:0006095', 'Wide tufts of distal phalanges', 'MP:0002543', 'brachyphalangia', 0.4084507042253521, 6.999816954161665, 1.6908814755552477, 'UPHENO:0087369', 'abnormal phalanx morphology'),
(349389, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349390, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349391, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349392, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349393, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349394, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349395, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349396, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349397, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349398, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349399, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349400, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349401, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349402, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349403, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349404, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349405, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349406, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349407, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349408, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349409, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349410, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349411, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349412, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349413, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349414, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349415, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349416, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349417, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349418, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349419, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349420, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349421, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349422, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349423, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349424, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349425, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349426, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349427, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349428, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349429, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349430, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349431, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349432, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349433, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349434, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349435, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349436, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349437, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349438, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349439, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349440, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349441, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349442, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349443, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349444, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349445, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349446, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349447, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349448, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349449, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349450, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349451, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349452, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349453, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349454, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349455, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349456, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349457, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349458, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349459, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349460, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349461, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349462, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349463, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349464, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349465, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349466, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349467, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349468, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349469, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349470, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349471, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349472, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349473, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349474, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349475, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349476, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349477, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349478, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349479, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349480, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349481, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349482, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349483, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349484, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349485, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349486, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349487, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349488, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349489, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349490, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349491, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349492, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349493, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349494, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349495, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349496, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349497, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349498, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349499, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349500, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349501, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349502, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349503, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349504, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349505, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349506, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349507, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349508, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349509, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349510, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349511, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349512, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349513, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349514, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349515, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349516, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349517, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349518, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349519, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349520, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349521, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349522, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349523, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349524, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349525, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349526, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349527, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349528, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349529, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349530, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349531, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349532, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349533, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349534, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349535, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349536, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349537, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349538, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349539, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349540, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349541, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349542, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349543, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349544, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349545, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349546, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349547, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349548, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349549, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349550, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349551, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349552, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349553, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349554, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349555, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349556, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349557, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349558, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349559, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349560, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349561, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349562, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349563, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349564, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349565, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349566, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349567, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349568, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349569, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349570, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349571, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349572, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349573, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349574, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349575, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349576, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349577, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349578, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349579, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349580, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349581, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349582, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349583, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349584, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349585, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349586, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349587, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349588, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349589, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349590, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349591, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349592, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349593, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349594, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349595, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349596, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349597, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349598, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349599, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349600, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349601, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349602, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349603, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349604, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349605, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349606, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349607, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349608, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349609, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349610, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349611, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349612, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349613, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349614, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349615, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349616, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349617, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349618, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349619, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349620, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349621, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349622, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349623, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349624, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349625, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349626, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349627, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349628, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349629, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349630, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349631, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349632, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349633, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349634, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349635, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349636, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349637, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349638, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349639, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349640, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349641, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349642, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349643, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349644, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349645, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349646, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349647, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349648, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349649, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349650, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349651, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349652, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349653, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349654, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349655, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349656, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349657, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349658, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349659, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349660, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349661, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349662, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349663, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(349664, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349665, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(349666, 'HP:5000032', 'Anti-SEZ6L2 antibody', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
